Clinical Trials Directory

Trials / Completed

CompletedNCT01862510

Detection of Celiac Disease in Patients With Hypothyroidism

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
University of Vermont · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The study evaluates whether hypothyroid patients requiring elevated doses of levothyroxine to maintain a euthyroid state are at increased risk of having celiac disease. It also attempts to determine if there is a threshold level of levothyroxine needed to maintain a euthyroid state in patients with hypothyroidism that should prompt serologic testing for celiac disease.

Detailed description

This study is looking at whether hypothyroid patients who require above 125 mcg/day (or \>1.5mcg/kg/day) of levothyroxine are more likely to have celiac disease than those who require smaller doses. It also looks to see if the prevalence of celiac disease in hypothyroid patients who require elevated doses of levothyroxine is high enough to warrant screening in that population.

Conditions

Timeline

Start date
2012-03-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2013-05-24
Last updated
2014-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01862510. Inclusion in this directory is not an endorsement.

Detection of Celiac Disease in Patients With Hypothyroidism (NCT01862510) · Clinical Trials Directory